Taft partner Peter French was quoted in the article “High court hands win to drugmakers in preemption case,” which was published by Business Insurance on May 28. The article discusses the May 20 Supreme Court’s ruling in Merck Sharp & Dohme Corp. v. Albrecht et al. that said judges, not juries, must decide the preemption question.
French is an experienced trial lawyer who has represented clients in litigation matters in many jurisdictions across the United States. He has represented clients in a wide variety of contexts, including class actions, False Claims Act lawsuits, strict product liability claims, intellectual property infringement matters, securities matters, shareholder disputes, real estate development and construction disputes, false advertising and unfair competition cases, breach of contract cases, commercial mortgage foreclosures and insurance coverage matters.